Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer (Mycobacterium ulcerans Disease)

A Chauty, MF Ardant, A Adeye, H Euverte… - Antimicrobial agents …, 2007 - Am Soc Microbiol
According to recommendations of the 6th WHO Advisory Committee on Buruli ulcer, directly
observed treatment with the combination of rifampin and streptomycin, administered daily for …

Aquatic Snails, Passive Hosts of Mycobacterium ulcerans

…, P Legras, AL Manceau, A Chauty… - Applied and …, 2004 - Am Soc Microbiol
Accumulative indirect evidence of the epidemiology of Mycobacterium ulcerans infections
causing chronic skin ulcers (ie, Buruli ulcer disease) suggests that the development of this …

[HTML][HTML] Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study

…, C Johnson, L Abel, L Marsollier, A Chauty… - The Lancet Global …, 2014 - thelancet.com
Background Buruli ulcer, caused by Mycobacterium ulcerans, was identified as a neglected
emerging infectious disease by WHO in 1998. Although Buruli ulcer is the third most …

[HTML][HTML] Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority …

…, FS Sarfo, T Wilson, G Sarpong, T Gateau, A Chauty… - The Lancet, 2020 - thelancet.com
Background Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans
infection that damages the skin and subcutis. It is most prevalent in western and central …

Oral Treatment for Mycobacterium ulcerans Infection: Results From a Pilot Study in Benin

A Chauty, MF Ardant, L Marsollier… - Clinical Infectious …, 2011 - academic.oup.com
Mycobacterium ulcerans infection is responsible for severe skin lesions in sub-Saharan Africa.
We enrolled 30 Beninese patients with Buruli ulcers in a pilot study to evaluate efficacy of …

[HTML][HTML] Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?

MT Ruf, A Chauty, A Adeye, MF Ardant… - PLoS neglected …, 2011 - journals.plos.org
Background The neglected tropical disease Buruli ulcer (BU) caused by Mycobacterium
ulcerans is an infection of the subcutaneous tissue leading to chronic ulcerative skin lesions. …

[HTML][HTML] Contribution of the community health volunteers in the control of Buruli ulcer in Bénin

…, AD Dossou, JG Houezo, A Chauty… - PLoS Neglected …, 2014 - journals.plos.org
Background Buruli ulcer (BU) is a neglected tropical disease caused by Mycobacterium
ulcerans. Usually BU begins as a painless nodule, plaque or edema, ultimately developing into …

Multiple Introductions and Recent Spread of the Emerging Human Pathogen Mycobacterium ulcerans across Africa

…, L Marsollier, E Marion, A Chauty… - Genome biology and …, 2017 - academic.oup.com
Buruli ulcer (BU) is an insidious neglected tropical disease. Cases are reported around the
world but the rural regions of West and Central Africa are most affected. How BU is …

[HTML][HTML] Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva

…, A Marot, CM Wondje, JP Saint-André, A Chauty… - Plos …, 2007 - journals.plos.org
Background Buruli ulcer is a severe human skin disease caused by Mycobacterium
ulcerans . This disease is primarily diagnosed in West Africa with increasing incidence. …

[HTML][HTML] Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway

…, I Theodorou, MF Ardant, E Marion, A Chauty… - Communications …, 2020 - nature.com
Buruli ulcer, caused by Mycobacterium ulcerans and characterized by devastating necrotizing
skin lesions, is the third mycobacterial disease worldwide. The role of host genetics in …